{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:22:01Z","timestamp":1794345721709,"version":"4.9.0"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jare.2026.02.051","type":"journal-article","created":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T22:51:30Z","timestamp":1772405490000},"page":"947-964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["From scaffold to effector: reframing GFAP in neurodegeneration"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8792-8310","authenticated-orcid":false,"given":"Yong-Heng","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9306-2267","authenticated-orcid":false,"given":"Chuan-Bin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8733-0322","authenticated-orcid":false,"given":"Yu-Hang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Hui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Yin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3385-7137","authenticated-orcid":false,"given":"Jiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2026.02.051_b0005","doi-asserted-by":"crossref","first-page":"29983","DOI":"10.1074\/jbc.M112121200","article-title":"A new splice variant of glial fibrillary acidic protein, GFAP epsilon, interacts with the presenilin proteins","volume":"277","author":"Nielsen","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2026.02.051_b0010","doi-asserted-by":"crossref","first-page":"15576","DOI":"10.1007\/s12035-025-05219-3","article-title":"The Role of Glial Fibrillary Acidic Protein in the Neuropathology of Alzheimer's Disease and its potential as a Blood Biomarker for Early Diagnosis and Progression","volume":"62","author":"Bandara","year":"2025","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jare.2026.02.051_b0015","doi-asserted-by":"crossref","DOI":"10.1093\/procel\/pwaf042","article-title":"Spatiotemporal characterization of disease-associated neurons in the entorhinal cortex-hippocampal circuit during AD progression","author":"Ma","year":"2025","journal-title":"Protein Cell"},{"key":"10.1016\/j.jare.2026.02.051_b0020","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2524111122","article-title":"The intermediate filament protein GFAP regulates mitochondrial fission in astrocytes","volume":"122","author":"Xiong","year":"2025","journal-title":"PNAS"},{"key":"10.1016\/j.jare.2026.02.051_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114206","article-title":"Metabolic perspective of astrocyte dysfunction in Alzheimer's disease and type 2 diabetes brains","volume":"158","author":"Shen","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jare.2026.02.051_b0030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s43587-023-00565-0","article-title":"Plasma proteomic profiles predict future dementia in healthy adults","volume":"4","author":"Guo","year":"2024","journal-title":"Nat Aging"},{"key":"10.1016\/j.jare.2026.02.051_b0035","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12916-024-03418-8","article-title":"Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK Biobank","volume":"22","author":"Wang","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.jare.2026.02.051_b0040","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1002\/alz.12879","article-title":"Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Abeta-PET, neurodegeneration, and cognition","volume":"19","author":"Chatterjee","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jare.2026.02.051_b0045","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/brain\/awac399","article-title":"Plasma biomarker profiles in autosomal dominant Alzheimer's disease","volume":"146","author":"Johansson","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.jare.2026.02.051_b0050","doi-asserted-by":"crossref","unstructured":"Leipp, F. et al. Glial fibrillary acidic protein in Alzheimer's disease: a narrative review. Brain Commun 6, fcae396, doi:10.1093\/braincomms\/fcae396 (2024).","DOI":"10.1093\/braincomms\/fcae396"},{"key":"10.1016\/j.jare.2026.02.051_b0055","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202001767R","article-title":"New GFAP splice isoform (GFAPmicro) differentially expressed in glioma translates into 21 kDa N-terminal GFAP protein","volume":"35","author":"van Bodegraven","year":"2021","journal-title":"FASEB J"},{"key":"10.1016\/j.jare.2026.02.051_b0060","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","article-title":"Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker","volume":"38","author":"Yang","year":"2015","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jare.2026.02.051_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042823","article-title":"GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease","volume":"7","author":"Kamphuis","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jare.2026.02.051_b0070","doi-asserted-by":"crossref","DOI":"10.1177\/17590914221102065","article-title":"GFAP Alternative Splicing and the Relevance for Disease - a Focus on Diffuse Gliomas","volume":"14","author":"van Asperen","year":"2022","journal-title":"ASN Neuro"},{"key":"10.1016\/j.jare.2026.02.051_b0075","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0169-328X(95)00010-P","article-title":"A novel glial fibrillary acidic protein mRNA lacking exon 1","volume":"30","author":"Zelenika","year":"1995","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.jare.2026.02.051_b0080","doi-asserted-by":"crossref","unstructured":"Pacoova Dal Maschio, V. et al. The Role of Blood-Based Biomarkers in Transforming Alzheimer's Disease Research and Clinical Management: A Review. Int J Mol Sci 26, doi:10.3390\/ijms26178564 (2025).","DOI":"10.3390\/ijms26178564"},{"key":"10.1016\/j.jare.2026.02.051_b0085","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.3389\/fimmu.2018.02802","article-title":"Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: a Review of the Literature","volume":"9","author":"Shan","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jare.2026.02.051_b0090","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.neurobiolaging.2013.09.035","article-title":"Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease","volume":"35","author":"Kamphuis","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jare.2026.02.051_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.859247","article-title":"GFAPdelta: a Promising Biomarker and Therapeutic Target in Glioblastoma","volume":"12","author":"Radu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jare.2026.02.051_b0100","doi-asserted-by":"crossref","first-page":"e7663","DOI":"10.1371\/journal.pone.0007663","article-title":"Specific human astrocyte subtype revealed by affinity purified GFAP antibody; unpurified serum cross-reacts with neurofilament-L in Alzheimer","volume":"4","author":"Middeldorp","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jare.2026.02.051_b0105","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.16226","article-title":"The GFAP proteoform puzzle: how to advance GFAP as a fluid biomarker in neurological diseases","volume":"169","author":"Gogishvili","year":"2025","journal-title":"J Neurochem"},{"key":"10.1016\/j.jare.2026.02.051_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2024.102340","article-title":"GFAP-isoforms in the nervous system: Understanding the need for diversity","volume":"87","author":"de Reus","year":"2024","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.jare.2026.02.051_b0115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ceb.2015.02.004","article-title":"Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system","volume":"32","author":"Hol","year":"2015","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.jare.2026.02.051_b0120","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1016\/S0021-9258(19)39622-X","article-title":"Phosphorylation sites linked to glial filament disassembly in vitro locate in a non-alpha-helical head domain","volume":"265","author":"Inagaki","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2026.02.051_b0125","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.47789","article-title":"Site-specific phosphorylation and caspase cleavage of GFAP are new markers of Alexander disease severity","volume":"8","author":"Battaglia","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.jare.2026.02.051_b0130","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1007\/s00018-016-2239-5","article-title":"GFAP isoforms control intermediate filament network dynamics, cell morphology, and focal adhesions","volume":"73","author":"Moeton","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jare.2026.02.051_b0135","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/cne.20102","article-title":"Increased citrullinated glial fibrillary acidic protein in secondary progressive multiple sclerosis","volume":"473","author":"Nicholas","year":"2004","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.jare.2026.02.051_b0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2014.05.007","article-title":"Localisation of citrullinated proteins in normal appearing white matter and lesions in the central nervous system in multiple sclerosis","volume":"273","author":"Bradford","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jare.2026.02.051_b0145","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3389\/fimmu.2019.00540","article-title":"Brain Citrullination patterns and T Cell Reactivity of Cerebrospinal Fluid-Derived CD4(+) T Cells in Multiple Sclerosis","volume":"10","author":"Faigle","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jare.2026.02.051_b0150","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.freeradbiomed.2018.04.007","article-title":"The cysteine residue of glial fibrillary acidic protein is a critical target for lipoxidation and required for efficient network organization","volume":"120","author":"Viedma-Poyatos","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jare.2026.02.051_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102415","article-title":"Alexander disease GFAP R239C mutant shows increased susceptibility to lipoxidation and elicits mitochondrial dysfunction and oxidative stress","volume":"55","author":"Viedma-Poyatos","year":"2022","journal-title":"Redox Biol"},{"key":"10.1016\/j.jare.2026.02.051_b0160","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1042\/BST20231059","article-title":"Type III intermediate filaments in redox interplay: key role of the conserved cysteine residue","volume":"52","author":"Pajares","year":"2024","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.jare.2026.02.051_b0165","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021642","article-title":"Type III Intermediate Filaments Desmin, Glial Fibrillary Acidic Protein (GFAP), Vimentin, and Peripherin","volume":"9","author":"Hol","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jare.2026.02.051_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071604","article-title":"The Diversity of Intermediate Filaments in Astrocytes","volume":"9","author":"Potokar","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jare.2026.02.051_b0175","doi-asserted-by":"crossref","first-page":"23996","DOI":"10.1074\/jbc.274.34.23996","article-title":"Intermediate filament protein partnership in astrocytes","volume":"274","author":"Eliasson","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2026.02.051_b0180","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1523\/JNEUROSCI.1709-08.2008","article-title":"STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury","volume":"28","author":"Herrmann","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.jare.2026.02.051_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102003","article-title":"Early activation of STAT3 regulates reactive astrogliosis induced by diverse forms of neurotoxicity","volume":"9","author":"O'Callaghan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jare.2026.02.051_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/cells12070978","article-title":"STAT3 Drives GFAP Accumulation and Astrocyte Pathology in a Mouse Model of Alexander Disease","volume":"12","author":"Hagemann","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jare.2026.02.051_b0195","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.conb.2021.10.002","article-title":"Alexander disease: models, mechanisms, and medicine","volume":"72","author":"Hagemann","year":"2022","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.jare.2026.02.051_b0200","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200296","article-title":"Genotype-Phenotype Association for 14 GFAP Variants in Alexander Disease","volume":"11","author":"Messing","year":"2025","journal-title":"Neurol Genet"},{"key":"10.1016\/j.jare.2026.02.051_b0205","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1021\/acs.jproteome.6b00316","article-title":"Composition of Rosenthal Fibers, the Protein Aggregate Hallmark of Alexander Disease","volume":"15","author":"Heaven","year":"2016","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jare.2026.02.051_b0210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1086\/504411","article-title":"The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of alpha B-crystallin and HSP27","volume":"79","author":"Der Perng","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jare.2026.02.051_b0215","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0092-8674(89)90173-6","article-title":"Alpha B-crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain","volume":"57","author":"Iwaki","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.jare.2026.02.051_b0220","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fncel.2019.00316","article-title":"Mitochondria are Dynamically Transferring between Human Neural Cells and Alexander Disease-Associated GFAP Mutations Impair the Astrocytic transfer","volume":"13","author":"Gao","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.jare.2026.02.051_b0225","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/humu.24400","article-title":"Type II Alexander disease caused by splicing errors and aberrant overexpression of an uncharacterized GFAP isoform","volume":"43","author":"Helman","year":"2022","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jare.2026.02.051_b0230","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ana.25118","article-title":"Antisense suppression of glial fibrillary acidic protein as a treatment for Alexander disease","volume":"83","author":"Hagemann","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jare.2026.02.051_b0235","doi-asserted-by":"crossref","unstructured":"Hagemann, T. L. et al. Antisense therapy in a rat model of Alexander disease reverses GFAP pathology, white matter deficits, and motor impairment. Sci Transl Med 13, eabg4711, doi:10.1126\/scitranslmed.abg4711 (2021).","DOI":"10.1126\/scitranslmed.abg4711"},{"key":"10.1016\/j.jare.2026.02.051_b0240","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12974-020-01915-0","article-title":"Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition","volume":"17","author":"Price","year":"2020","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jare.2026.02.051_b0245","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.899251","article-title":"The Role of Astrocytes in Synapse loss in Alzheimer's Disease: a Systematic Review","volume":"16","author":"Hulshof","year":"2022","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.jare.2026.02.051_b0250","doi-asserted-by":"crossref","first-page":"e2696","DOI":"10.1038\/cddis.2017.89","article-title":"Aberrant iPSC-derived human astrocytes in Alzheimer's disease","volume":"8","author":"Jones","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jare.2026.02.051_b0255","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1002\/alz.13720","article-title":"Tracing synaptic loss in Alzheimer's brain with SV2A PET-tracer UCB-J","volume":"20","author":"Kumar","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jare.2026.02.051_b0260","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/alz.12097","article-title":"In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET","volume":"16","author":"Mecca","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jare.2026.02.051_b0265","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jare.2026.02.051_b0270","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.233019","article-title":"Plasma Glial Fibrillary Acid Protein and Phosphorated Tau 181 Association with Presynaptic Density-Dependent Tau Pathology at (18)F-SynVesT-1 Brain PET Imaging","volume":"313","author":"Wu","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.jare.2026.02.051_b0275","article-title":"Prediction of longitudinal synaptic loss in Alzheimer's disease using tau PET and plasma biomarkers","volume":"21","author":"Wang","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jare.2026.02.051_b0280","doi-asserted-by":"crossref","unstructured":"Swanson, M. J., Lewis, K. N., Carpenter, R., Whetzel, A. & Bae, N. S. The human RAP1 and GFAPvarepsilon proteins increase gamma-secretase activity in a yeast model system. G3 (Bethesda) 13, doi:10.1093\/g3journal\/jkad057 (2023).","DOI":"10.1093\/g3journal\/jkad057"},{"key":"10.1016\/j.jare.2026.02.051_b0285","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3233\/JPD-230284","article-title":"Astrocytes and Alpha-Synuclein: Friend or Foe?","volume":"13","author":"Ozoran","year":"2023","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.jare.2026.02.051_b0290","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nbt.1957","article-title":"Astrocytes from familial and sporadic ALS patients are toxic to motor neurons","volume":"29","author":"Haidet-Phillips","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jare.2026.02.051_b0295","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3233\/JAD-200608","article-title":"Serum Glial Fibrillary Acidic Protein (GFAP) is a Marker of Disease Severity in Frontotemporal Lobar Degeneration","volume":"77","author":"Benussi","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jare.2026.02.051_b0300","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1136\/jnnp-2021-326487","article-title":"GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance","volume":"92","author":"Katisko","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jare.2026.02.051_b0305","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/jnnp-2019-321954","article-title":"Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia","volume":"91","author":"Heller","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jare.2026.02.051_b0310","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41392-025-02299-4","article-title":"Glioblastoma at the crossroads: current understanding and future therapeutic horizons","volume":"10","author":"Singh","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jare.2026.02.051_b0315","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/awm263","article-title":"Serum GFAP is a diagnostic marker for glioblastoma multiforme","volume":"130","author":"Jung","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jare.2026.02.051_b0320","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11060-015-1978-8","article-title":"Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma","volume":"126","author":"Tichy","year":"2016","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jare.2026.02.051_b0325","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41598-021-04127-5","article-title":"GFAP splice variants fine-tune glioma cell invasion and tumour dynamics by modulating migration persistence","volume":"12","author":"Uceda-Castro","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2026.02.051_b0330","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/glia.23594","article-title":"Importance of GFAP isoform-specific analyses in astrocytoma","volume":"67","author":"van Bodegraven","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.jare.2026.02.051_b0335","article-title":"Reactive Astrocytes in Glioma: Emerging Opportunities and challenges","volume":"26","author":"Wu","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2026.02.051_b0340","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/s12967-024-05301-9","article-title":"The tumour microenvironment, treatment resistance and recurrence in glioblastoma","volume":"22","author":"White","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.jare.2026.02.051_b0345","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061879","article-title":"The Extracellular Matrix in Glioblastomas: a Glance at its Structural modifications in Shaping the Tumoral Microenvironment-a Systematic Review","volume":"15","author":"Marino","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jare.2026.02.051_b0350","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1254694","article-title":"The role of angiogenic growth factors in the immune microenvironment of glioma","volume":"13","author":"Ge","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.jare.2026.02.051_b0355","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1093\/brain\/awab223","article-title":"Plasma GFAP is an early marker of amyloid-beta but not tau pathology in Alzheimer's disease","volume":"144","author":"Pereira","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.jare.2026.02.051_b0360","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1002\/alz.13157","article-title":"Longitudinal changes in Alzheimer's-related plasma biomarkers and brain amyloid","volume":"19","author":"Bilgel","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jare.2026.02.051_b0365","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1089\/neu.2024.0581","volume":"42","author":"Bazarian","year":"2025","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.jare.2026.02.051_b0370","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1177\/0271678X231172520","article-title":"Quantification and prospective evaluation of serum NfL and GFAP as blood-derived biomarkers of outcome in acute ischemic stroke patients","volume":"43","author":"Ferrari","year":"2023","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jare.2026.02.051_b0375","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14134746","article-title":"Performance of GFAP and UCH-L1 for Early Acute Stroke Diagnosis in the Emergency Department","volume":"14","author":"Popa","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.jare.2026.02.051_b0380","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S1474-4422(25)00249-2","article-title":"Blood and CSF biomarkers for multiple sclerosis: emerging clinical applications","volume":"24","author":"Chitnis","year":"2025","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jare.2026.02.051_b0385","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/jnnp-2020-323487","article-title":"Diagnostic and prognostic value of serum NfL and p-Tau(181) in frontotemporal lobar degeneration","volume":"91","author":"Benussi","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jare.2026.02.051_b0390","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jare.2026.02.051_b0395","doi-asserted-by":"crossref","first-page":"10412","DOI":"10.1038\/s41467-025-66728-2","article-title":"Blood biomarkers of Alzheimer's disease and progression across different stages of cognitive decline in the community","volume":"16","author":"Valletta","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2026.02.051_b0400","doi-asserted-by":"crossref","DOI":"10.1177\/1759091420981206","article-title":"Regulation of GFAP Expression","volume":"13","author":"Brenner","year":"2021","journal-title":"ASN Neuro"},{"key":"10.1016\/j.jare.2026.02.051_b0405","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/toxsci\/kfaa115","article-title":"NF-kappaB Signaling in Astrocytes Modulates Brain Inflammation and Neuronal Injury following Sequential Exposure to Manganese and MPTP during Development and Aging","volume":"177","author":"Hammond","year":"2020","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jare.2026.02.051_b0410","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fncel.2015.00278","article-title":"Elusive roles for reactive astrocytes in neurodegenerative diseases","volume":"9","author":"Ben Haim","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.jare.2026.02.051_b0415","doi-asserted-by":"crossref","first-page":"38634","DOI":"10.1074\/jbc.M604942200","article-title":"Synergistic effects of the SAPK\/JNK and the proteasome pathway on glial fibrillary acidic protein (GFAP) accumulation in Alexander disease","volume":"281","author":"Tang","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2026.02.051_b0420","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/hmg\/ddn042","article-title":"Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38\/MAPK and mTOR signaling pathways","volume":"17","author":"Tang","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jare.2026.02.051_b0425","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1242\/jcs.073874","article-title":"Chaperone-mediated autophagy at a glance","volume":"124","author":"Kaushik","year":"2011","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jare.2026.02.051_b0430","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/EBC20160001","article-title":"Proteostasis regulation by the ubiquitin system","volume":"60","author":"Bett","year":"2016","journal-title":"Essays Biochem"},{"key":"10.1016\/j.jare.2026.02.051_b0435","doi-asserted-by":"crossref","unstructured":"Li, L. et al. GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease. Cell Stem Cell 23, 239-251 e236, doi:10.1016\/j.stem.2018.07.009 (2018).","DOI":"10.1016\/j.stem.2018.07.009"},{"key":"10.1016\/j.jare.2026.02.051_b0440","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1093\/nar\/gkw533","article-title":"Splice-switching antisense oligonucleotides as therapeutic drugs","volume":"44","author":"Havens","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jare.2026.02.051_b0445","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jare.2026.02.051_b0450","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1038\/s41467-019-11707-7","article-title":"Moving beyond the glial scar for spinal cord repair","volume":"10","author":"Bradbury","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2026.02.051_b0455","doi-asserted-by":"crossref","unstructured":"Lauffer, M. C., van Roon-Mom, W., Aartsma-Rus, A. & Collaborative, N. Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders. Commun Med (Lond) 4, 6, doi:10.1038\/s43856-023-00419-1 (2024).","DOI":"10.1038\/s43856-023-00419-1"},{"key":"10.1016\/j.jare.2026.02.051_b0460","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jconrel.2023.01.067","article-title":"AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges","volume":"355","author":"Kang","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.jare.2026.02.051_b0465","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1038\/s41467-023-42746-w","article-title":"A toolbox of astrocyte-specific, serotype-independent adeno-associated viral vectors using microRNA targeting sequences","volume":"14","author":"Gleichman","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2026.02.051_b0470","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jare.2026.02.051_b0475","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41586-023-07011-6","article-title":"Spatial transcriptomics reveal neuron-astrocyte synergy in long-term memory","volume":"627","author":"Sun","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jare.2026.02.051_b0480","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41593-025-01878-6","article-title":"Astrocyte heterogeneity reveals region-specific astrogenesis in the white matter","volume":"28","author":"Bocchi","year":"2025","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jare.2026.02.051_b0485","doi-asserted-by":"crossref","unstructured":"Schroeder, M. E. et al. A transcriptomic atlas of astrocyte heterogeneity across space and time in mouse and marmoset. Neuron 113, 3942-3965 e3919, doi:10.1016\/j.neuron.2025.09.011 (2025).","DOI":"10.1016\/j.neuron.2025.09.011"},{"key":"10.1016\/j.jare.2026.02.051_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135028","article-title":"Characterization of human iPSC-derived astrocytes with potential for disease modeling and drug discovery","volume":"731","author":"Soubannier","year":"2020","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jare.2026.02.051_b0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113310","article-title":"Cerebral organoids derived from patients with Alzheimer's disease with PSEN1\/2 mutations have defective tissue patterning and altered development","volume":"42","author":"Vanova","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.jare.2026.02.051_b0500","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.stemcr.2017.10.016","article-title":"PSEN1 Mutant iPSC-derived Model reveals Severe Astrocyte Pathology in Alzheimer's Disease","volume":"9","author":"Oksanen","year":"2017","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jare.2026.02.051_b0505","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1002\/alz.13390","article-title":"Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia","volume":"19","author":"Winchester","year":"2023","journal-title":"Alzheimers Dement"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123226001852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123226001852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T20:34:29Z","timestamp":1794342869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123226001852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":101,"alternative-id":["S2090123226001852"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2026.02.051","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From scaffold to effector: reframing GFAP in neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2026.02.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}